Robotics
PrivateNOT INVESTABLE — the turnaround thesis already paid out; AMETEK bought FARO for $44/sh cash (~40% premium, ~$920M, ~2.7x sales) and delisted it on 21-Jul-2025. The equity no longer exists; the only live read is as an AMETEK (AME) margin-expansion input.
Research
The verdict
NOT INVESTABLE — the turnaround thesis already paid out; AMETEK bought FARO for $44/sh cash (~40% premium, ~$920M, ~2.7x sales) and delisted it on 21-Jul-2025. The equity no longer exists; the only live read is as an AMETEK (AME) margin-expansion input.
Primary sources
Source documents — open to read in full
FARO is a 3D measurement, imaging, and "realization" company — Florida corporation, founded 1981/1982, HQ Lake Mary, FL. It designs, builds, markets and services software-driven 3D capture hardware — portable coordinate-measuring arms, laser scanners, and trackers — plus the software that turns that capture into usable models, for four end markets: manufacturing, architecture/engineering/construction (AEC), operations & maintenance (O&M), and public-safety analytics. The pitch in plain terms: replace tape measures and chalk lines with ultra-high-accuracy digital capture, cutting rework and quality costs.
Revenue mix (FY2024):
Product families — the taxonomy shows the CyberOptics/software pivot in motion:
Contract structure: predominantly transactional hardware sales + a growing subscription/maintenance annuity. No take-or-pay, no customer concentration — the opposite of an AI-infrastructure name. Ten largest customers were only ~4.2% of total sales in 2024 — thousands of industrial customers, from small machine shops to large OEMs. This diversification is a genuine quality signal (no single-customer cliff) and is precisely why FARO fit AMETEK's aftermarket-heavy model.
Customers/suppliers/competitors: end markets skew automotive, aerospace, heavy equipment (all cyclical). Key supplier: Sanmina (contract manufacturer, see Lens 2). Competitors: Hexagon, Zeiss, Nikon, Mitutoyo, Keyence, Renishaw, KLA, Creaform (Lens 3/7).
The single most important supply-chain fact — and the one that both fixed the margins and created the tariff risk — is the outsourcing to Sanmina:
Upstream inputs → FARO → end customer:
Chokepoint / single-source dependency: the Sanmina Thailand facility is now the concentration risk. A single central manufacturing node is efficient but fragile — and it sits in a country flagged for a potential additional 36% US import tariff (see Lens 5/13). FARO's own risk factors name the "benefits of our partnership with Sanmina" and "inability to reasonably source essential [components]" as explicit dependencies. This is not generic — the named node is Sanmina/Thailand, and it is the pivot on which both the margin story and the tariff risk turn.
(Commercial-layer note: the robotics-beat supply-chain.md wiki is generic to the robotics frontier and does not map to FARO's metrology-instrument supply chain; the filing is the authoritative source here.)
FARO is a credible #2–#3 in portable 3D metrology, but not a category king — and the moat is real but narrow:
Bargaining power: weak over suppliers (dependent on Sanmina; a natural FX hedge but no pricing whip), and moderate over customers (diversified base — no single customer can dictate terms, but customers can defer purchases in a downturn, which is exactly what happened in 2024). The durable weakness: FARO sells discretionary capital equipment into cyclical industrial end-markets. When automotive/aerospace/China capex softens, orders evaporate — there is no recurring-contract floor large enough to offset it (service is only 24% of revenue). Hexagon is structurally larger, better-funded, and broader — the reason FARO ends up an acquisition target rather than a consolidator.
FARO reports as one operating segment but discloses product/service and geographic splits. (The empty segments.csv on the shelf means these are read directly from the filing.)
By product line (FY2024 vs FY2023):
| Line | FY2024 | FY2023 | Δ | % of total |
|---|---|---|---|---|
| Product | $260.2M | $278.6M | −6.6% | 76.0% |
| Service | $82.2M | $80.3M | +2.5% | 24.0% |
| Total | $342.4M | $358.8M | −4.6% | 100% |
The trend: hardware decelerating (cyclical demand), service resilient — service is the annuity that holds up through the cycle, which is why the software/subscription pivot matters strategically even though it's still a minority of revenue.
By geography (FY2024 revenue):
| Region | FY2024 revenue | ~% of total |
|---|---|---|
| United States & Canada | $141.2M | ~41% |
| Germany | $45.9M | ~13% |
| Asia-Other | $27.1M | ~8% |
| China | $26.9M | ~8% |
| Japan | $21.7M | ~6% |
| Americas-Other | $17.1M | ~5% |
| Rest of Europe | (balance) | ~19% |
Cause of the FY2024 decline: China + US together drove a $15.0M sales drop on "challenging macroeconomic environment," plus a $1.7M FX drag from a weak Japanese Yen. In Q1-2025 the same pattern: APAC down $1.4M, "driven by most of the end markets within China". China weakness is the recurring segment story. More than 61% of revenue is invoiced in foreign currencies — a natural hedge (matched-currency costs), no FX derivatives used.
The number that defines FARO: in Q1-2025, FARO swung to GAAP profitability on essentially flat revenue — the clearest single frame of the turnaround.
Q1-2025 (three months ended 31-Mar-2025):
| Metric | Q1-2025 | Q1-2024 | Δ |
|---|---|---|---|
| Total sales | $82.9M | $84.2M | −1.6% |
| Gross profit | $47.2M | $43.3M | +9.1% |
| Gross margin | 57.0% | 51.4% | +5.6pts |
| SG&A | $33.8M | $39.6M | −14.6% |
| Operating income | $3.8M | −$5.3M | +$9.1M swing |
| Net income | $0.9M ($0.05/sh) | −$7.3M (−$0.38/sh) | +$8.2M swing |
The engine is cost, not growth: revenue basically flat, but gross margin +5.6pts (product GM to 58.5% on better Arm/Scanner ASPs + lower material cost from the Sanmina consolidation) and SG&A down $5.8M (2024 Restructuring Plan savings + lower commissions). Non-GAAP EPS $0.33, "significantly beating" forecasts. Q2-2025 guidance was $79–87M revenue / $0.20–0.40 non-GAAP EPS — but Q2 was never reported standalone (deal closed 21-Jul-2025).
Full-year FY2024 for context:
Balance sheet (Q1-2025):
Balance-sheet flags: none alarming. Receivables $87.0M and inventory $32.1M both fell YoY while revenue fell modestly — working capital tightened, not loosened (a positive). The main flag was the 870.7% effective tax rate FY2024 / 63.2% Q1-2025 — a mechanical artifact of near-breakeven pre-tax income + valuation allowances (tax expense in profitable jurisdictions not offset by benefits in loss-making ones), not an accounting red flag.
Market reaction: N/A as a standalone — the stock's decisive move was the +40% pop to $44 on the 6-May-2025 deal announcement; it then traded pinned near $44 into the 21-Jul close. 52-week range $22.18–$44.06 — i.e., the deal price nearly doubled the low. What the market "reacted to" for FARO, in the end, was a takeout bid.
No transcripts on the shelf (transcripts/ empty). From secondary sources across the last independent quarters, management tone traced a clear arc:
Recurring phrases: "margin expansion," "operating cash flow," "software and hardware integration," "one central manufacturing facility." Things they stopped saying: the crisis/restructuring vocabulary of 2023 — the story had visibly moved from survival to profitable growth by early 2025. That completed narrative arc is what made FARO sellable at a premium.
FARO's own multiple is now fixed by the deal, so the most useful comp is the price AMETEK paid vs the peer set.
The deal multiple:
Peer table — public 3D/industrial-metrology names (multiples are current market, not the FARO deal):
| Company | Ticker | Mkt cap | EV/Sales | EV/EBIT | P/E | Div yld | 5y avg ROE | Note |
|---|---|---|---|---|---|---|---|---|
| Hexagon AB | HEXA-B (STO) | n/a | n/a | n/a | n/a | n/a | n/a | Category leader; largest installed base |
| ZEISS (Carl Zeiss) | private/segment | n/a | n/a | n/a | n/a | n/a | n/a | Industrial Quality & Research segment |
| Nikon (Metrology) | 7731 (TYO) | n/a | n/a | n/a | n/a | n/a | n/a | Metrology is a small segment of Nikon |
| Keyence | 6861 (TYO) | n/a | n/a | n/a | n/a | n/a | n/a | Premium multiple; sensors + measurement |
| Renishaw | RSW (LSE) | n/a | n/a | n/a | n/a | n/a | n/a | Rising challenger |
| AMETEK (acquirer) | AME | n/a | n/a | n/a | n/a | n/a | n/a | Now owns FARO; EIG op margin 28.3% Q3-25 |
| FARO | FARO | delisted | ~2.7x (deal) | ~15x adj-EBITDA (deal) [est] | n/a — acquired | 0% (never paid) | negative (loss-making 2022–24) | $44/sh cash, 21-Jul-2025 |
The FARO tape was a cyclical de-rating followed by a takeout. Pattern from the record:
What the market actually reacts to for FARO: (1) the industrial capex cycle (China + automotive/aerospace), (2) margin/restructuring proof-points, and ultimately (3) M&A. Earnings beats mattered less than the macro backdrop and the takeout — a small-cap cyclical whose terminal catalyst was consolidation.
The management story is the turnaround-CEO archetype who delivered and exited via sale — arguably the cleanest possible outcome for a professional operator brought in to fix a broken small-cap.
Peter Lau — President & CEO from 24-Jul-2023:
insider-transactions.csv not on the shelf → no precise holdings figure; n/a for exact ownership %.Acting as a forensic analyst on the last independent filings: the accounting is notably clean — the earnings quality actually improved into the sale.
Regulatory findings (from regulatory/regulatory-findings.md + web + Item 3):
No standalone EPS projection is meaningful — FARO's forward EPS as an independent entity is undefined from 21-Jul-2025 onward. The equity was extinguished at $44.00/share cash; there is no future free-float earnings stream to model. Per the skill's --watchlist rule, no Brier forecast is logged (nothing to resolve).
What can be framed:
Bull case (why the deal made sense / why it was the right outcome): FARO was a de-risked, cash-generative niche leader — #2–#3 in portable 3D metrology, large installed base, diversified customer set (top-10 = 4.2%), a growing software annuity (Sphere XG, BuildIT), a freshly asset-light cost structure (Sanmina), a clean balance sheet (net cash), and a decade-high margin trajectory. For a serial compounder like AMETEK, that is a textbook bolt-on: buy the fixed business, plug it into a 28%-margin platform, expand. The 40% premium was earned by the turnaround.
Bear case (what the acquirer/holder still has to watch): (1) Cyclicality is unrepealed — FARO never regained its 2018 revenue peak; automotive/aerospace/China capex still governs demand, and a downturn compresses the hardware line fast. (2) Tariff exposure — the Sanmina/Thailand concentration collides with a potential +36% US tariff; a real gross-margin threat management itself flagged. (3) The margin recovery was cost-led on flat revenue — you cannot cut your way to growth forever; the durable question is whether the software pivot can actually re-accelerate the top line.
Pre-mortem (had it stayed independent, thesis breaks 18 months out): a 2025–26 industrial recession + tariff-driven COGS spike would have stalled the margin story, revenue would have slid back toward $310–320M, and the "double-digit EBITDA at scale" narrative would have unwound — re-rating the small-cap back toward its $22 low. The sale removed exactly this tail risk for FARO holders — cash at $44 was the risk-off outcome.
Multiples too high? The ~2.7x sales / ~15x adj-EBITDA deal price was full but defensible — not a bubble multiple for a recovering instruments franchise, which is why the board could unanimously endorse it and shareholders approved.
Contrarian view the market missed: the market treated FARO as a perennially-disappointing small-cap cyclical — but the asset-light Sanmina model + software mix had structurally reset the margin ceiling, making the earnings power worth far more to a strategic operator than to public markets pricing the cycle. AMETEK saw the reset earnings power; the public float was still pricing the old FARO.
Dismantling the bull — what could/would still break how this business makes money (relevant now to the AME thesis and to the historical read):
(For a live independent FARO these would go to Peter Lau; post-close they read as AMETEK-integration diligence questions on the FARO unit.)
The #1 knee/hip implant franchise priced for failure (~12x fwd EPS) — but it is the value trap until it proves organic growth can clear 3% without the Paragon/Monogram M&A crutch and stops losing the robotics war to Mako. Cheap is the thesis and the warning.
A cheap, well-run AIDC compounder mis-tagged "robotics" — it just SOLD its robots; the real bet is whether ~4% organic hardware growth + buybacks + a tariff-refund kicker re-rates a 13x stub the Street already targets at $330.
A near-breakeven Chinese smart-EV OEM whose margin (GM 18.9% FY25, ~20% Q1'26) and a high-margin VW software-licensing annuity are real — but FY26 volume has rolled over (-22.6% YTD), and the IRON/eVTOL/robotaxi "embodied-AI" optionality the bulls pay for is unproven cash-burn; long the software+margin inflection at a 52-week-low multiple, but only if the GX/new-model cycle re-accelerates deliveries by 2H26.